Skip to main content
Figure 7 | Journal of Translational Medicine

Figure 7

From: Combined IL-21 and Low-Dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model

Figure 7

Cytokine flow cytometry analysis of the functional phenotype of pmel CD8+ splenocytes from IL-21 + IL-2 treated mice. Spleen cells were pooled from 2 mice with progressing tumors (≥ 50 mm2) and from 2 mice with regressing tumors (<10 mm2) 42 days after vaccination. Cytokine flow cytometry analysis shows the absolute number of pmel CD8+ T cells per 106 splenocytes (A), and the frequency of pmel CD8+ cells (B) that are positive for IL-2, IFNγ, and TNFγ production. Data show mice with regressing tumors had 4.7-fold, 4.8-fold and 2.5-fold more IL-2+, IFN-γ+, and TNF-α+ pmel CD8+ T cells respectively, and higher frequencies of Tc1 cytokine+ cells than progressor mice.

Back to article page